Работы, на которые ссылается эта работа
Работ: 133
Работа: Breast cancer vaccines; A comprehensive and updated review
Current and future burden of breast cancer: Global statistics for 2020 and 2040
Melina Arnold, Eileen Morgan, Harriet Rumgay +8
Статья2022Цитирований: 8ABIHuman Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic Implications
Nida Iqbal, Nida Iqbal, Naveed Iqbal +1
Обзорная статья2014Цитирований: 6ABINeoantigens: promising targets for cancer therapy
Na Xie, Guobo Shen, Wei Gao +3
Обзорная статья2023Цитирований: 6ABIRoles of the immune system in cancer: from tumor initiation to metastatic progression
Hugo González, Catharina Hagerling, Zena Werb
Обзорная статья2018Цитирований: 4ABIBreast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis
Yixiao Feng, Mia Spezia, Shifeng Huang +15
Обзорная статья2018Цитирований: 4ABIUnderstanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies, Edward W. Roberts, Kelly Kersten +15
Обзорная статья2018Цитирований: 4ABICTLA-4 and PD-1 Pathways
Elizabeth I. Buchbinder, Anupam M. Desai
Обзорная статья2015Цитирований: 3ABIDendritic cell subsets in cancer immunity and tumor antigen sensing
Annalisa Del Prete, Valentina Salvi, Alessandra Soriani +4
Обзорная статья2023Цитирований: 3ABITriple-negative breast cancer molecular subtyping and treatment progress
Li Yin, Jiang-Jie Duan, Xiu-Wu Bian +1
Обзорная статья2020Цитирований: 3ABImRNA vaccines — a new era in vaccinology
Norbert Pardi, Michael J. Hogan, Frederick Porter +1
Обзорная статья2018Цитирований: 3ABICytotoxic CD8+ T cells in cancer and cancer immunotherapy
Hans Raskov, Adile Orhan, Jan Pravsgaard Christensen +1
Обзорная статья2020Цитирований: 3ABITargeting HER2-positive breast cancer: advances and future directions
Sandra M. Swain, Mythili Shastry, Erika Hamilton
Обзорная статья2022Цитирований: 3ABIThe Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses
Alireza Labani‐Motlagh, Mehrnoush Ashja-Mahdavi, Angelica Loskog
Обзорная статья2020Цитирований: 2ABIHarnessing the immune system to improve cancer therapy
Nikos E. Papaioannou, Ourania V. Beniata, Panagiotis Vitsos +2
Обзорная статья2016Цитирований: 2ABIImmunosuppression in tumor immune microenvironment and its optimization from CAR-T cell therapy
Zaoqu Liu, Zhaokai Zhou, Qin Dang +4
Обзорная статья2022Цитирований: 2ABIBiological subtypes of breast cancer: Prognostic and therapeutic implications
Обзорная статья2014Цитирований: 2ABICD28 and CTLA‐4 coreceptor expression and signal transduction
Christopher E. Rudd, Alison Taylor, Helga Schneider
Обзорная статья2009Цитирований: 2ABITargeted therapies in breast cancer: New challenges to fight against resistance
Обзорная статья2017Цитирований: 2ABIEx vivo pulsed dendritic cell vaccination against cancer
Yangzhuo Gu, Xing Zhao, Xiangrong Song
Обзорная статья2020Цитирований: 2ABICancer Vaccines, Adjuvants, and Delivery Systems
Samantha Paston, Victoria A. Brentville, Peter Symonds +1
Обзорная статья2021Цитирований: 2ABIAspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance
Khalil Khalaf, Doris Hana, Jadzia Tin-Tsen Chou +3
Обзорная статья2021Цитирований: 2ABIMultidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches
Talha Bin Emran, Asif Shahriar, Aar Rafi Mahmud +13
Обзорная статья2022Цитирований: 2ABI